55154-2275 : Angiomax 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 55154-2275 |
Labeler: | Cardinal Health |
Product Type: | Human Prescription Drug |
Drug Name: | Angiomax |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA020873 |
Rev. Date: |
NDC Package Codes:
- 55154-2275-5: 5 VIAL, SINGLE‑USE IN 1 BAG (55154‑2275‑5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Bivalirudin
Dosage Strength:
- 250 mg
Pharmaceutical Classes:
- Anti-coagulant [EPC]
- Direct Thrombin Inhibitor [EPC]
- Thrombin Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0781-3447 Angiomax 250 mg Intravenous Injection by Sandoz Inc
- 65293-001 Angiomax 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55154-2233Next: 55154-2305 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.